Dainippon Sumitomo Pharma Co. Ltd - Articles and news items

Daiichi Sankyo logo

Dainippon Sumitomo Pharma and Daiichi Sankyo cooperate on lurasidone, an atypical antipsychotic agent, in four South American countries

Industry news / 27 May 2014 / Daiichi Sankyo

Dainippon Sumitomo Pharma Co., Ltd. and Daiichi Sankyo Co., Ltd. announced that they have entered into a license agreement for the commercialization of lurasidone hydrochloride…


Edison Pharma and Dainippon Sumitomo Pharma (DSP) enter $4 billion metablosim drug deal

Industry news / 31 January 2014 / Edison Pharmaceuticals

Novel partnership in drugs targeting biological energy…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...